EDGAR Filing Documents for 0001607062-20-000210

Form 8-K - Current report:

SEC Accession No. 0001607062-20-000210

Filing Date

2020-08-07

Accepted

2020-08-07 08:32:00

Documents

Period of Report

2020-08-04

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	gnbt080520form8k.htm	8-K	28623
2	EXHIBIT 4.1	ex4_1.htm	EX-4.1	143781
3	EXHIBIT 4.2	ex4_2.htm	EX-4.2	133273
4	EXHIBIT 4.3	ex4_3.htm	EX-4.3	135778
5	EXHIBIT 4.4	ex4_4.htm	EX-4.4	115686
6	EXHIBIT 4.5	ex4_5.htm	EX-4.5	173328
7	EXHIBIT 10.1	ex10_1.htm	EX-10.1	282982
8	GRAPHIC	image_001.gif	GRAPHIC	2363
	Complete submission text file	0001607062-20-000210.txt		1017920

Mailing Address 10102 USA TODAY WAY MIRAMAR FL 33025

Business Address 10102 USA TODAY WAY MIRAMAR FL 33025 416-364-2551

GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)